Shandong Teruilin Medicine Technology Development

Shandong Teruilin Pharmaceutical Technology Development is a prominent Chinese Clinical Research Organization (CRO) that provides a full suite of services for drug development and clinical trials. Established in 2013, the company specializes in bioequivalence (BE) studies, Phase I-IV clinical trials, and the consistency evaluation of generic drugs. Teruilin offers integrated solutions encompassing clinical operation, data management, statistical analysis, and regulatory submission support. With a focus on high-quality standards and efficient project management, the firm serves as a key partner for domestic and international pharmaceutical companies seeking market entry in China.